Documentation Centre

October 15, 2020
Assessment of long-term benefit of intensive blood pressure control on residual life span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Cardiol. 2020;5:1?6.
Vaduganathan M, Claggett BL, Juraschek SP, Solomon SD

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Age, Cardiovascular Disease, Hypertension